Basket

Record was added to the basket

1.Long-term safety, efficacy, and tolerability of recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin G in patients aged ≥ 18 years with primary immunodeficiencies

Long-term safety, efficacy, and tolerability of recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin G in patients aged ≥ 18 years with primary immunodeficiencies / Richard L. Wasserman ... [et al.] . Klinická imunológia a alergológia. - ISSN 1335-0013 . - Zv. 25, č. 3 (2015), s. 38

C 2659
Request a copy DDS
DSD service
From the basket
Citation
Bookmark

Selected documents
Citation

citace PRO
article

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.